While most immunotherapies focus on a single aspect of cancer immunity, ImmuneFx modulates the tumor microenvironment in multiple ways by priming, generating, guiding and augmenting both innate and adaptive immune pathways.
________________________________________________________________________
TME=tumor microenvironment; APCs=antigen presenting cells
__________________________________________________
__________________________________________________
___________________________________________________
___________________________________________________
ImmuneFx has the potential to broaden the applicability of checkpoint blockades by priming robust, patient-specific, multivalent responses in naïve, unresponsive, or refractory patients
Copyright © 2021 Morphogenesis, Inc. - All Rights Reserved.
Powered by GoDaddy